Colleran David has filed 43 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 4694 shares of Anika Therapeutics, Inc. ($ANIK) on March 14, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | A | Common Stock | 4694 | $0.00 | 67,182.0000 | 14,419,000 | 7.51% | 0.03% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 4168 | $14.20 | 63,014.0000 | 14,419,000 | 6.20% | 0.03% |
| March 15, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 6449 | $0.00 | 69,463.0000 | 14,419,000 | 10.23% | 0.04% |
| March 15, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 1893 | $14.20 | 67,570.0000 | 14,419,000 | 2.73% | 0.01% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 9388 | $0.00 | 18,777.0000 | 14,419,000 | 33.33% | 0.07% |
| March 15, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 6449 | $0.00 | 6,448.0000 | 14,419,000 | 50.00% | 0.04% |
| March 14, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 9388 | $0.00 | 62,488.0000 | 14,419,000 | 17.68% | 0.07% |
| March 9, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 1919 | $14.96 | 53,100.0000 | 14,419,000 | 3.49% | 0.01% |
| March 9, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 5465 | $0.00 | 55,019.0000 | 14,419,000 | 11.03% | 0.04% |
| March 9, 2026 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 5465 | $0.00 | 0.0000 | 14,419,000 | 100.00% | 0.04% |
| March 14, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | A | Restricted Stock Unit | 13669 | $0.00 | 13,669.0000 | 14,721,000 | 9999.99% | 0.09% |
| March 17, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 6448 | $0.00 | 12,897.0000 | 14,721,000 | 33.33% | 0.04% |
| March 17, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 6448 | $0.00 | 49,847.0000 | 14,721,000 | 14.86% | 0.04% |
| March 17, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 1893 | $15.91 | 47,954.0000 | 14,721,000 | 3.80% | 0.01% |
| March 14, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | A | Restricted Stock Unit | 28165 | $0.00 | 28,165.0000 | 14,721,000 | 9999.99% | 0.19% |
| March 11, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 7663 | $0.00 | 45,649.0000 | 14,721,000 | 20.17% | 0.05% |
| March 11, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 7663 | $0.00 | 0.0000 | 14,721,000 | 100.00% | 0.05% |
| March 11, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 2250 | $16.79 | 43,399.0000 | 14,721,000 | 4.93% | 0.02% |
| March 10, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 1604 | $16.62 | 37,986.0000 | 14,721,000 | 4.05% | 0.01% |
| March 10, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 5465 | $0.00 | 39,590.0000 | 14,721,000 | 16.01% | 0.04% |
| March 10, 2025 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 5465 | $0.00 | 5,465.0000 | 14,721,000 | 50.00% | 0.04% |
| March 15, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | A | Stock Option (Right to Buy) | 46875 | $0.00 | 46,875.0000 | 14,656,000 | 9999.99% | 0.32% |
| March 15, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | A | Restricted Stock Unit | 19345 | $0.00 | 19,345.0000 | 14,656,000 | 9999.99% | 0.13% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 7662 | $0.00 | 7,663.0000 | 14,656,000 | 50.00% | 0.05% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 3682 | $0.00 | 24,804.0000 | 14,656,000 | 17.43% | 0.03% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 1081 | $25.42 | 23,723.0000 | 14,656,000 | 4.36% | 0.01% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 5465 | $0.00 | 29,188.0000 | 14,656,000 | 23.04% | 0.04% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 1605 | $25.42 | 27,583.0000 | 14,656,000 | 5.50% | 0.01% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 7662 | $0.00 | 35,245.0000 | 14,656,000 | 27.78% | 0.05% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 2250 | $25.79 | 32,995.0000 | 14,656,000 | 6.38% | 0.02% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 3682 | $0.00 | 0.0000 | 14,656,000 | 100.00% | 0.03% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 5465 | $0.00 | 10,930.0000 | 14,656,000 | 33.33% | 0.04% |
| March 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 7663 | $0.00 | 22,538.0000 | 14,787,000 | 51.52% | 0.05% |
| March 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 2250 | $26.10 | 20,288.0000 | 14,787,000 | 9.98% | 0.02% |
| March 10, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 7663 | $0.00 | 15,325.0000 | 14,787,000 | 33.33% | 0.05% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | A | Stock Option (Right to Buy) | 35790 | $0.00 | 35,790.0000 | 14,787,000 | 9999.99% | 0.24% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 3683 | $0.00 | 3,682.0000 | 14,787,000 | 50.01% | 0.02% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 3683 | $0.00 | 15,956.0000 | 14,787,000 | 30.01% | 0.02% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 1081 | $26.91 | 14,875.0000 | 14,787,000 | 6.77% | 0.01% |
| March 9, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | A | Restricted Stock Unit | 16395 | $0.00 | 16,395.0000 | 14,787,000 | 9999.99% | 0.11% |
| March 4, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Restricted Stock Unit | 2500 | $0.00 | 0.0000 | 14,787,000 | 100.00% | 0.02% |
| March 4, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | F | Common Stock | 734 | $31.59 | 12,273.0000 | 14,787,000 | 5.64% | 0.00% |
| March 4, 2023 | Anika Therapeutics, Inc. | $ANIK | Colleran David | EVP, General Counsel, Corp Sec | M | Common Stock | 2500 | $0.00 | 13,007.0000 | 14,787,000 | 23.79% | 0.02% |